XTL BIOPHARMACEUTICALS LTD 4

Accession 0000909012-08-000425

$XTLBCIK 0001023549other

View on SEC.gov Company Profile

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 2:22 PM ET

Size

21.7 KB

Accession

0000909012-08-000425

Insider Transaction Report

Form 4

Period: 2008-03-04

XTL BIOPHARMACEUTICALS LTDXTLB

EDELMAN JOSEPH

10% Owner

Transactions

Purchase
Ordinary Shares
2008-03-04$3.99/sh+104,060$415,137→ 49,888,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-05$3.94/sh+535,800$2,110,302→ 50,706,280 total(indirect: see footnotes)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+6,640$26,490→ 2,623,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.98/sh+18,000$71,656→ 2,616,840 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.98/sh+282,000$1,122,614→ 50,170,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-05$3.94/sh+34,200$134,700→ 2,657,680 total(indirect: see footnote)

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

10% Owner

Transactions

Purchase
Ordinary Shares
2008-03-04$3.98/sh+282,000$1,122,614→ 50,170,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+104,060$415,137→ 49,888,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.98/sh+18,000$71,656→ 2,616,840 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-05$3.94/sh+34,200$134,700→ 2,657,680 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-05$3.94/sh+535,800$2,110,302→ 50,706,280 total(indirect: see footnotes)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+6,640$26,490→ 2,623,480 total(indirect: see footnote)

PERCEPTIVE ADVISORS LLC

10% Owner

Transactions

Purchase
Ordinary Shares
2008-03-04$3.98/sh+282,000$1,122,614→ 50,170,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-05$3.94/sh+535,800$2,110,302→ 50,706,280 total(indirect: see footnotes)
Purchase
Ordinary Shares
2008-03-05$3.94/sh+34,200$134,700→ 2,657,680 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+104,060$415,137→ 49,888,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.98/sh+18,000$71,656→ 2,616,840 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+6,640$26,490→ 2,623,480 total(indirect: see footnote)

Cho Michael

10% Owner

Transactions

Purchase
Ordinary Shares
2008-03-05$3.94/sh+34,200$134,700→ 2,657,680 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.98/sh+18,000$71,656→ 2,616,840 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+6,640$26,490→ 2,623,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+104,060$415,137→ 49,888,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.98/sh+282,000$1,122,614→ 50,170,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-05$3.94/sh+535,800$2,110,302→ 50,706,280 total(indirect: see footnotes)

Bradley Scott

10% Owner

Transactions

Purchase
Ordinary Shares
2008-03-05$3.94/sh+535,800$2,110,302→ 50,706,280 total(indirect: see footnotes)
Purchase
Ordinary Shares
2008-03-04$3.98/sh+282,000$1,122,614→ 50,170,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.98/sh+18,000$71,656→ 2,616,840 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+104,060$415,137→ 49,888,480 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-05$3.94/sh+34,200$134,700→ 2,657,680 total(indirect: see footnote)
Purchase
Ordinary Shares
2008-03-04$3.99/sh+6,640$26,490→ 2,623,480 total(indirect: see footnote)

Footnotes (3)

[F1]This Form 4 is being filed by Joseph Edelman, Michael Cho, Scott Bradley, Perceptive Life Science Master Fund Ltd. ("Master Fund") and Perceptive Advisors LLC ("Advisors").
[F2]This transaction was effected through the Master Fund. Mr. Edelman is the managing member of Advisors, which in turn serves as the investment manager of Master Fund. Mr. Edelman and Mr. Bradley share dispositive power over 1,010,000 of such shares and Mr. Edelman and Mr. Cho share dispositive power of 2,409,350 of such shares. Mr. Edelman has sole voting and dispositive power over the remainder of such shares. In accordance with Instruction 4(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund is reported herein. Each of Mr. Edelman, Mr. Cho, Mr. Bradley and Advisors disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary therein, and this report shall not be deemed an admission that Mr. Edelman, Mr. Cho, Mr. Bradley and Advisors is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
[F3]This transaction was effected through an account at First New York Trading, LLC. Mr. Edelman and Mr. Cho share dispositive power over 267,670 of such shares and Mr. Edelman has sole voting and dispositive power over the remainder of such shares. Mr. Edelman and Mr. Cho each disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman or Mr. Cho is the beneficial owner of such securities for purposes of Sectioin 16 or for any other purposes. Mr. "Bradley disclaims beneficial ownership over all such shares.

Documents

2 files

Issuer

XTL BIOPHARMACEUTICALS LTD

CIK 0001023549

→

Entity typeother

IncorporatedIsrael

Related Parties

filerCIK 0001023549

Filing Metadata

Form type: 4
Filed: Mar 9, 8:00 PM ET
Accepted: Mar 10, 2:22 PM ET
Size: 21.7 KB

View on SEC.gov